Ami Fadia
Stock Analyst at Needham
(3.29)
# 994
Out of 4,876 analysts
427
Total ratings
43.73%
Success rate
3.07%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $22.21 | +35.07% | 10 | Jun 26, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $57 | $37.48 | +52.08% | 24 | Jun 24, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $9 | $3.19 | +182.13% | 17 | Jun 18, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $7.34 | - | 23 | Jun 17, 2025 | |
| SAGE Sage Therapeutics | Reiterates: Hold | n/a | $9.28 | - | 22 | Jun 16, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $44.26 | +80.75% | 12 | Jun 12, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $126.92 | - | 41 | Jun 12, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $107.59 | +87.75% | 32 | Jun 11, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $153 → $150 | $102.57 | +46.24% | 15 | Jun 9, 2025 | |
| BPMC Blueprint Medicines | Downgrades: Hold | $130 | $128.15 | +1.44% | 31 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $13.04 | +168.40% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $28.83 | +56.09% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $88 | $53.18 | +65.48% | 29 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.80 | +525.47% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.29 | +104.63% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $27 | $6.48 | +316.67% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $31.86 | +53.80% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $126.71 | +9.70% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.28 | +298.35% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $15.90 | +1,912.58% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.60 | +217.80% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $1.02 | +2,105.88% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $26.57 | +137.11% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $3.98 | +25.63% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $16.56 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $2.16 | +918.52% | 4 | Jan 3, 2018 |
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $22.21
Upside: +35.07%
Revolution Medicines
Jun 24, 2025
Reiterates: Buy
Price Target: $57
Current: $37.48
Upside: +52.08%
Immuneering
Jun 18, 2025
Reiterates: Buy
Price Target: $9
Current: $3.19
Upside: +182.13%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.34
Upside: -
Sage Therapeutics
Jun 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.28
Upside: -
Praxis Precision Medicines
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $44.26
Upside: +80.75%
Biogen
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $126.92
Upside: -
Jazz Pharmaceuticals
Jun 11, 2025
Reiterates: Buy
Price Target: $202
Current: $107.59
Upside: +87.75%
Axsome Therapeutics
Jun 9, 2025
Maintains: Buy
Price Target: $153 → $150
Current: $102.57
Upside: +46.24%
Blueprint Medicines
Jun 2, 2025
Downgrades: Hold
Price Target: $130
Current: $128.15
Upside: +1.44%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $13.04
Upside: +168.40%
May 28, 2025
Initiates: Buy
Price Target: $45
Current: $28.83
Upside: +56.09%
May 23, 2025
Maintains: Buy
Price Target: $75 → $88
Current: $53.18
Upside: +65.48%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $0.80
Upside: +525.47%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $9.29
Upside: +104.63%
May 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $6.48
Upside: +316.67%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $31.86
Upside: +53.80%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $126.71
Upside: +9.70%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.28
Upside: +298.35%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $15.90
Upside: +1,912.58%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.60
Upside: +217.80%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $1.02
Upside: +2,105.88%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $26.57
Upside: +137.11%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $3.98
Upside: +25.63%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $16.56
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $2.16
Upside: +918.52%